These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 2093781

  • 21. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K, Niederau C, Frieling T.
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [Abstract] [Full Text] [Related]

  • 25. [Comparison of the indexes of serologic activity with endoscopy in intestinal inflammatory disease].
    Martínez Salmerón JF, Rodrigo M, Nogueras F, de Sola C, Corral C, Ortega C, Martín-Vivaldi R.
    Gastroenterol Hepatol; 1996 Jul; 19(7):344-6. PubMed ID: 8963902
    [Abstract] [Full Text] [Related]

  • 26. [Inflammatory bowel disease activity index: clinical and laboratory indicators].
    Dichi I, Burini RC.
    Arq Gastroenterol; 1995 Jul; 32(3):121-30. PubMed ID: 8728787
    [Abstract] [Full Text] [Related]

  • 27. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
    Zilberman L, Maharshak N, Arbel Y, Rogowski O, Rozenblat M, Shapira I, Berliner S, Arber N, Dotan I.
    Digestion; 2006 Jul; 73(4):205-9. PubMed ID: 16837810
    [Abstract] [Full Text] [Related]

  • 28. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M, Richter L, Bosseckert H, Eitner K.
    Hepatogastroenterology; 1999 Jul; 46(28):2333-7. PubMed ID: 10521992
    [Abstract] [Full Text] [Related]

  • 29. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkühn T, Parhofer KG, Göke B, Broedl UC.
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
    Sharif F, McDermott M, Dillon M, Drumm B, Rowland M, Imrie C, Kelleher S, Harty S, Bourke B.
    Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
    [Abstract] [Full Text] [Related]

  • 32. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV.
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [Abstract] [Full Text] [Related]

  • 33. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
    Letizia C, D'Ambrosio C, Agostini D, Corsi A, Boirivant M, Pallone F, Scavo D.
    Ital J Gastroenterol; 1993 Jan; 25(1):23-5. PubMed ID: 8381313
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC.
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [Abstract] [Full Text] [Related]

  • 38. Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection.
    Petersen AM, Schou C, Mirsepasi H, Engberg J, Friis-Møller A, Nordgaard-Lassen I, Wildt S, Krogfelt KA.
    Scand J Gastroenterol; 2012 Feb; 47(2):155-61. PubMed ID: 22150030
    [Abstract] [Full Text] [Related]

  • 39. Clinically active Crohn's disease in the presence of a low C-reactive protein.
    Florin TH, Paterson EW, Fowler EV, Radford-Smith GL.
    Scand J Gastroenterol; 2006 Mar; 41(3):306-11. PubMed ID: 16497618
    [Abstract] [Full Text] [Related]

  • 40. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C, Descos L, André F, Vignal J, Druguet M.
    Gastroenterol Clin Biol; 1979 Nov; 3(11):789-94. PubMed ID: 527789
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.